News NVIDIA sinks $2bn into AI cloud provider Nebius NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius to ramp up infrastructure as demand soars in the life sciences.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.